Cargando…
Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation
Hematopoietic cell transplant (HCT) is an increasingly common and curative treatment strategy to improve survival among individuals with malignant and nonmalignant diseases, with over one million HCTs having been performed worldwide. Neurocognitive dysfunction is a common and untoward consequence of...
Autores principales: | Smith, Patrick J., Lew, Meagan, Lowder, Yen, Romero, Kristi, Thompson, Jillian C., Bohannon, Lauren, Pittman, Alyssa, Artica, Alexandra, Ramalingam, Sendhilnathan, Choi, Taewoong, Gasparetto, Cristina, Horwitz, Mitchell, Long, Gwynn, Lopez, Richard, Rizzieri, David, Sarantopoulos, Stefanie, Sullivan, Keith, Chao, Nelson, Sung, Anthony D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037500/ https://www.ncbi.nlm.nih.gov/pubmed/34667271 http://dx.doi.org/10.1038/s41409-021-01470-z |
Ejemplares similares
-
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
por: Green, Michael M. B., et al.
Publicado: (2016) -
A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant
por: Ramalingam, Sendhilnathan, et al.
Publicado: (2021) -
Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality
por: Maung, Ko, et al.
Publicado: (2020) -
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
por: Pabon, Cindy M., et al.
Publicado: (2021) -
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
por: Kanda, Junya, et al.
Publicado: (2011)